search
Back to results

Optimization of Hearing Performance in the Subject Implanted (OPERSA)

Primary Purpose

Hearing Loss

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Program A
Program B
Control
Sponsored by
University Hospital, Toulouse
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hearing Loss focused on measuring deafness, cochlear implant

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age>18
  • Unilaterally postlingually-deafened adult cochlear implanted candidates (IC-Uni)
  • Person with almost normal or moderate contralateral hearing ( under 60dB)
  • Cochlear implanted person whose activation has not yet been performed
  • Cochlear implanted subjects with bilateral post-lingual profound deafness, who already benefit from a unilateral cochlear implant and candidates to a bilateral cochlear implant
  • Affiliated to social security

Exclusion Criteria:

  • - Subjects under juridical protections or tutelage measure
  • Subjects with associated neurological or neurodegenerative conditions
  • Significant anatomical changes on CT scan of the temporal bone that may interfere with the insertion of the cochlear implant

Sites / Locations

  • MarxRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Active Comparator

Arm Label

Training A

Training B

Control

Arm Description

Training A in Unilaterally postlingually-deafened adult cochlear implanted candidates

Training B in Unilaterally postlingually-deafened adult cochlear implanted candidates

Training in bilaterally postlingually-deafened adult cochlear implanted candidates

Outcomes

Primary Outcome Measures

The primary outcome is the percentage of correct speech recognition after training between the two training programs

Secondary Outcome Measures

Full Information

First Posted
March 1, 2022
Last Updated
August 22, 2023
Sponsor
University Hospital, Toulouse
Collaborators
Centre National de la Recherche Scientifique, France
search

1. Study Identification

Unique Protocol Identification Number
NCT05325450
Brief Title
Optimization of Hearing Performance in the Subject Implanted
Acronym
OPERSA
Official Title
Optimization of Hearing Performance in the Subject Implanted With Profound Asymmetric Deafness
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 18, 2023 (Actual)
Primary Completion Date
January 18, 2025 (Anticipated)
Study Completion Date
January 18, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Toulouse
Collaborators
Centre National de la Recherche Scientifique, France

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
In the past two decades, the selection criteria for cochlear implantation have been greatly relaxed so that about 60-70% of present cochlear implant (CI) candidates have significant residual hearing in their contralateral ear. However, contralateral hearing is often not considered in rehabilitation programs, mainly due to the lack of scientific evidence on the role it may play. The present project aims to better understand the mechanisms of perceptual learning of CI-processed speech after implantation and to develop and test rehabilitation strategies for CI users.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hearing Loss
Keywords
deafness, cochlear implant

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
two within-subject crossover experiments (short-term and long-term) where each subject will follow two phases of the protocol (training A and training B).
Masking
None (Open Label)
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Training A
Arm Type
Experimental
Arm Description
Training A in Unilaterally postlingually-deafened adult cochlear implanted candidates
Arm Title
Training B
Arm Type
Experimental
Arm Description
Training B in Unilaterally postlingually-deafened adult cochlear implanted candidates
Arm Title
Control
Arm Type
Active Comparator
Arm Description
Training in bilaterally postlingually-deafened adult cochlear implanted candidates
Intervention Type
Procedure
Intervention Name(s)
Program A
Intervention Description
Presentation of the sentence to the implant alone
Intervention Type
Procedure
Intervention Name(s)
Program B
Intervention Description
Presentation of the sentence to the implanted ear, associated for the non-implanted ear
Intervention Type
Procedure
Intervention Name(s)
Control
Intervention Description
Presentation of the sentences alternately to the most recently implanted ear and both implanted ears at the same time
Primary Outcome Measure Information:
Title
The primary outcome is the percentage of correct speech recognition after training between the two training programs
Time Frame
Month 12

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age>18 Unilaterally postlingually-deafened adult cochlear implanted candidates (IC-Uni) Person with almost normal or moderate contralateral hearing ( under 60dB) Cochlear implanted person whose activation has not yet been performed Cochlear implanted subjects with bilateral post-lingual profound deafness, who already benefit from a unilateral cochlear implant and candidates to a bilateral cochlear implant Affiliated to social security Exclusion Criteria: - Subjects under juridical protections or tutelage measure Subjects with associated neurological or neurodegenerative conditions Significant anatomical changes on CT scan of the temporal bone that may interfere with the insertion of the cochlear implant
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mathieu MARX
Phone
0561777704
Email
marx.m@chu-toulouse.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Nadege ALGANS
Phone
0561777204
Email
algans.n@chu-toulouse.fr
Facility Information:
Facility Name
Marx
City
Toulouse
Country
France
Individual Site Status
Recruiting

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Optimization of Hearing Performance in the Subject Implanted

We'll reach out to this number within 24 hrs